Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q2 2024 Earnings Call Transcript
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q2 2024 Earnings Call Transcript August 13, 2024Singular Genomics Systems, Inc. beats earnings expectations.
Singular Genomics Systems Inc. (OMIC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 166,162 | $1,404,069 | 0.02% | |
| 2. | Perceptive Advisors Joseph Edelman | 70,896 | $599,071 | 0.01% | |
| 3. | Casdin Capital Eli Casdin | 44,129 | $372,890 | 0.02% | |
| 4. | OrbiMed Advisors Samuel Isaly | 18,023 | $152,294 | 0% | |
| 5. | Casdin Capital Eli Casdin | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.21 | 32,000 | 372,000 | 2024-09-18 | Filing | ||
| $15.33 | 40,000 | 340,000 | 2024-09-17 | Filing | ||
| $12.74 | 50,416 | 300,000 | 2024-09-16 | Filing | ||
| $0.42 | 75,000 | Officer, Director | 4,061,206 | 2023-11-17 | Filing | |
| $0.41 | 43,468 | Officer, Director | 3,986,206 | 2023-11-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.38 | 175 | 637 | 2024-09-15 | Filing | ||
| $0.53 | 200,000 | Director | 3,763,985 | 2023-08-15 | Filing | |
| $0.57 | 77,991 | Director | 3,963,985 | 2023-08-14 | Filing | |
| $0.60 | 353,657 | Director | 4,041,976 | 2023-08-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 126,630.86,666,667 | $1,747,886 | 1.06% | |
| 2. | 77,321.433,333,333 | $1,067,268 | 0.89% | |
| 3. | 73,645 | $1,016,301 | 0% | |
| 4. | 70,654.5 | $975,244 | 0% | |
| 5. | 62,419.4 | $861,575 | 0% |
News See All
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q1 2024 Earnings Call Transcript
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q1 2024 Earnings Call Transcript May 14, 2024Singular Genomics Systems, Inc. beats earnings expectations.
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript
Singular Genomics Systems, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.34.
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the Singular Genomics Systems, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions].
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q2 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Singular Genomics Systems, Inc. Second Quarter 2023 Earnings Conference Call.
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q1 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the Singular Genomics Systems, Incorporated First Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this conference is being recorded.
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Singular Genomics Systems, Incorporated Fourth Quarter 2022 Earnings Conference Call. Please note, this conference is being recorded.